Surface Oncology, Inc. SURF
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management GP, LLC | Texas | 0 | 3183242 | 0 | 3183242 | 3183242 | 5.24 % | 20/07/2023 |
| Daniel Schneeberger | Switzerland | 0 | 3183242 | 0 | 3183242 | 3183242 | 5.24 % | 20/07/2023 |
| ADAR1 Capital Management, LLC | Texas | 0 | 3183242 | 0 | 3183242 | 3183242 | 5.24 % | 20/07/2023 |
| ADAR1 Capital Management GP, LLC | Texas | 0 | 3183242 | 0 | 3183242 | 3183242 | 5.24 % | 20/07/2023 |
| ADAR1 Partners, LP | Delaware | 0 | 3183242 | 0 | 3183242 | 3183242 | 5.24 % | 20/07/2023 |
| ADAR1 Partners, LP | Delaware | 0 | 3183242 | 0 | 3183242 | 3183242 | 5.24 % | 20/07/2023 |
| Daniel Schneeberger | Switzerland | 0 | 3183242 | 0 | 3183242 | 3183242 | 5.24 % | 20/07/2023 |
| ADAR1 Capital Management, LLC | Texas | 0 | 3183242 | 0 | 3183242 | 3183242 | 5.24 % | 20/07/2023 |
| Atlas Venture Associates IX, L.P. | Delaware | 0 | 2945453 | 0 | 2945453 | 2945453 | 4.87 % | 31/01/2023 |
| Atlas Venture Associates IX, LLC | Delaware | 0 | 2945453 | 0 | 2945453 | 2945453 | 4.87 % | 31/01/2023 |
| Atlas Venture Fund IX, L.P. | Delaware | 0 | 2945453 | 0 | 2945453 | 2945453 | 4.87 % | 31/01/2023 |
| ARK Investment Management LLC | Delaware, United States | 6323533 | 0 | 6323533 | 0 | 6323533 | 11.58 % | 09/08/2022 |
| ARK Investment Management LLC | Delaware, United States | 6323533 | 0 | 6323533 | 0 | 6323533 | 11.58 % | 09/08/2022 |
| EcoR1 Capital, LLC | Delaware | 0 | 4653000 | 0 | 4653000 | 4653000 | 9.9 % | 14/03/2022 |
| Oleg Nodelman | United States | 0 | 4653000 | 0 | 4653000 | 4653000 | 9.9 % | 14/03/2022 |
| EcoR1 Capital Fund Qualified, L.P. | Delaware | 0 | 4330082 | 0 | 4330082 | 4330082 | 9.2 % | 14/03/2022 |
| EcoR1 Capital Fund Qualified, L.P. | Delaware | 0 | 4330082 | 0 | 4330082 | 4330082 | 9.2 % | 14/03/2022 |
| Oleg Nodelman | United States | 0 | 4653000 | 0 | 4653000 | 4653000 | 9.9 % | 14/03/2022 |
| EcoR1 Capital, LLC | Delaware | 0 | 4653000 | 0 | 4653000 | 4653000 | 9.9 % | 14/03/2022 |
| BlackRock, Inc. | Delaware | 2524323 | 0 | 2562685 | 0 | 2562685 | 5.6 % | 04/02/2022 |
| Atlas Venture Associates IX, LLC | Delaware | 0 | 2945453 | 0 | 2945453 | 2945453 | 6.38 % | 25/01/2022 |
| Atlas Venture Fund IX, L.P. | Delaware | 0 | 2945453 | 0 | 2945453 | 2945453 | 6.38 % | 25/01/2022 |
| Atlas Venture Associates IX, L.P. | Delaware | 0 | 2945453 | 0 | 2945453 | 2945453 | 6.38 % | 25/01/2022 |
| ARK Investment Management LLC | Delaware, United States | 4476420 | 0 | 4476420 | 0 | 4476420 | 10.31 % | 09/07/2021 |
| ARK Investment Management LLC | Delaware, United States | 4476420 | 0 | 4476420 | 0 | 4476420 | 10.31 % | 09/07/2021 |
| Venrock Healthcare Capital Partners II, L.P. | Delaware | 0 | 1442895 | 0 | 1442895 | 1442895 | 3.5 % | 16/02/2021 |
| VHCP CoInvestment Holdings III, LLC | Delaware | 0 | 1442895 | 0 | 1442895 | 1442895 | 3.5 % | 16/02/2021 |
| Venrock Healthcare Capital Partners III, L.P. | Delaware | 0 | 1442895 | 0 | 1442895 | 1442895 | 3.5 % | 16/02/2021 |
| VHCP CoInvestment Holdings II, LLC | Delaware | 0 | 1442895 | 0 | 1442895 | 1442895 | 3.5 % | 16/02/2021 |
| Koh, Bong | United States | 0 | 1442895 | 0 | 1442895 | 1442895 | 3.5 % | 16/02/2021 |
| Shah, Nimish | United States | 0 | 1442895 | 0 | 1442895 | 1442895 | 3.5 % | 16/02/2021 |
| VHCP Management III, LLC | Delaware | 0 | 1442895 | 0 | 1442895 | 1442895 | 3.5 % | 16/02/2021 |
| VHCP Management II, LLC | Delaware | 0 | 1442895 | 0 | 1442895 | 1442895 | 3.5 % | 16/02/2021 |
| EcoR1 Capital, LLC | Delaware | 0 | 0 | 0 | 0 | 9 | 0.1 % | 16/02/2021 |
| Oleg Nodelman | United States | 0 | 0 | 0 | 0 | 9 | 0.1 % | 16/02/2021 |
| EcoR1 Capital Fund Qualified, L.P. | Delaware | 0 | 0 | 0 | 0 | 9 | 0.1 % | 16/02/2021 |
| Steven E. Hall, Ph.D. | United States | 0 | 0 | 0 | 0 | 0 | 0 % | 10/02/2021 |
| LV Management Group, LLC | Delaware | 0 | 0 | 0 | 0 | 0 | 0 % | 10/02/2021 |
| S. Edward Torres | United States | 0 | 0 | 0 | 0 | 0 | 0 % | 10/02/2021 |
| Armen B. Shanafelt, Ph.D. | United States | 56173 | 0 | 56173 | 0 | 56173 | 0.1 % | 10/02/2021 |
| Novartis AG | Switzerland | 0 | 3948482 | 0 | 3948482 | 3948482 | 9.71 % | 08/02/2021 |
| Novartis AG | Switzerland | 0 | 3948482 | 0 | 3948482 | 3948482 | 9.71 % | 08/02/2021 |
| Novartis Institutes for BioMedical Research, Inc. | Delaware | 0 | 3948482 | 0 | 3948482 | 3948482 | 9.71 % | 08/02/2021 |
| Novartis Institutes for BioMedical Research, Inc. | Delaware | 0 | 3948482 | 0 | 3948482 | 3948482 | 9.71 % | 08/02/2021 |
| Atlas Venture Associates IX, L.P. | Delaware | 0 | 2945453 | 0 | 2945453 | 2945453 | 7.24 % | 02/02/2021 |
| Atlas Venture Associates IX, LLC | Delaware | 0 | 2945453 | 0 | 2945453 | 2945453 | 7.24 % | 02/02/2021 |
| Atlas Venture Fund IX, L.P. | Delaware | 0 | 2945453 | 0 | 2945453 | 2945453 | 7.24 % | 02/02/2021 |
| Abigail P. Johnson | United States of America | 0 | 0 | 2048321 | 0 | 2048321 | 5.035 % | 10/12/2020 |
| Abigail P. Johnson | United States of America | 0 | 0 | 2048321 | 0 | 2048321 | 5.035 % | 10/12/2020 |
| FMR LLC | Delaware | 1163056 | 0 | 2048321 | 0 | 2048321 | 5.035 % | 10/12/2020 |
| FMR LLC | Delaware | 1163056 | 0 | 2048321 | 0 | 2048321 | 5.035 % | 10/12/2020 |
| BVF Inc. | Delaware | 0 | 2125650 | 0 | 2125650 | 2125650 | 5.8 % | 29/05/2020 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 1112895 | 0 | 1112895 | 1112895 | 3.1 % | 29/05/2020 |
| Mark N. Lampert | United States | 0 | 2125650 | 0 | 2125650 | 2125650 | 5.8 % | 29/05/2020 |
| BVF I GP LLC | Delaware | 0 | 1112895 | 0 | 1112895 | 1112895 | 3.1 % | 29/05/2020 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 829367 | 0 | 829367 | 829367 | 2.3 % | 29/05/2020 |
| BVF II GP LLC | Delaware | 0 | 829367 | 0 | 829367 | 829367 | 2.3 % | 29/05/2020 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 144025 | 0 | 144025 | 144025 | 0 % | 29/05/2020 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 144025 | 0 | 144025 | 144025 | 0 % | 29/05/2020 |
| BVF GP HOLDINGS LLC | Delaware | 0 | 1942262 | 0 | 1942262 | 1942262 | 5.3 % | 29/05/2020 |
| BVF Partners L.P. | Delaware | 0 | 2125650 | 0 | 2125650 | 2125650 | 5.8 % | 29/05/2020 |
| BVF Inc. | Delaware | 0 | 2125650 | 0 | 2125650 | 2125650 | 5.8 % | 29/05/2020 |
| Mark N. Lampert | United States | 0 | 2125650 | 0 | 2125650 | 2125650 | 5.8 % | 29/05/2020 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 1112895 | 0 | 1112895 | 1112895 | 3.1 % | 29/05/2020 |
| BVF I GP LLC | Delaware | 0 | 1112895 | 0 | 1112895 | 1112895 | 3.1 % | 29/05/2020 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 829367 | 0 | 829367 | 829367 | 2.3 % | 29/05/2020 |
| BVF II GP LLC | Delaware | 0 | 829367 | 0 | 829367 | 829367 | 2.3 % | 29/05/2020 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 144025 | 0 | 144025 | 144025 | 0 % | 29/05/2020 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 144025 | 0 | 144025 | 144025 | 0 % | 29/05/2020 |
| BVF GP HOLDINGS LLC | Delaware | 0 | 1942262 | 0 | 1942262 | 1942262 | 5.3 % | 29/05/2020 |
| BVF Partners L.P. | Delaware | 0 | 2125650 | 0 | 2125650 | 2125650 | 5.8 % | 29/05/2020 |
| Oleg Nodelman | United States | 0 | 5033861 | 0 | 5033861 | 5033861 | 12.8 % | 29/05/2020 |
| EcoR1 Capital, LLC | Delaware | 0 | 5033861 | 0 | 5033861 | 5033861 | 12.8 % | 29/05/2020 |
| EcoR1 Capital Fund Qualified, L.P. | Delaware | 0 | 4262806 | 0 | 4262806 | 4262806 | 10.9 % | 29/05/2020 |
| EcoR1 Capital, LLC | Delaware | 0 | 5033861 | 0 | 5033861 | 5033861 | 12.8 % | 29/05/2020 |
| Oleg Nodelman | United States | 0 | 5033861 | 0 | 5033861 | 5033861 | 12.8 % | 29/05/2020 |
| EcoR1 Capital Fund Qualified, L.P. | Delaware | 0 | 4262806 | 0 | 4262806 | 4262806 | 10.9 % | 29/05/2020 |
| Venrock Healthcare Capital Partners II, L.P. | Delaware | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| Koh, Bong | United States | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| Shah, Nimish | United States | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| Koh, Bong | United States | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| VHCP CoInvestment Holdings II, LLC | Delaware | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| Shah, Nimish | United States | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| VHCP Management III, LLC | Delaware | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| VHCP Management II, LLC | Delaware | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| VHCP CoInvestment Holdings III, LLC | Delaware | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| Venrock Healthcare Capital Partners III, L.P. | Delaware | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| Venrock Healthcare Capital Partners II, L.P. | Delaware | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| VHCP CoInvestment Holdings II, LLC | Delaware | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| Venrock Healthcare Capital Partners III, L.P. | Delaware | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| VHCP CoInvestment Holdings III, LLC | Delaware | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| VHCP Management II, LLC | Delaware | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| VHCP Management III, LLC | Delaware | 0 | 3877895 | 0 | 3877895 | 3877895 | 9.9 % | 29/05/2020 |
| Atlas Venture Associates IX, LLC | Delaware | 0 | 4654453 | 0 | 4654453 | 4654453 | 16.69 % | 04/02/2020 |
| Atlas Venture Associates IX, L.P. | Delaware | 0 | 4654453 | 0 | 4654453 | 4654453 | 16.69 % | 04/02/2020 |
| Atlas Venture Fund IX, L.P. | Delaware | 0 | 4654453 | 0 | 4654453 | 4654453 | 16.69 % | 04/02/2020 |
| Atlas Venture Associates IX, LLC 2. ¨ | Delaware | 0 | 4654453 | 0 | 4654453 | 4654453 | 16.81 % | 08/02/2019 |
| Atlas Venture Fund IX, L.P. 2. ¨ | Delaware | 0 | 4654453 | 0 | 4654453 | 4654453 | 16.81 % | 08/02/2019 |
| Atlas Venture Associates IX, L.P. 2. ¨ | Delaware | 0 | 4654453 | 0 | 4654453 | 4654453 | 16.81 % | 08/02/2019 |
| Abigail P. Johnson | United States of America | 0 | 0 | 1752984 | 0 | 1752984 | 6.332 % | 20/12/2018 |
| FMR LLC | Delaware | 1647865 | 0 | 1752984 | 0 | 1752984 | 6.332 % | 20/12/2018 |
| FMR LLC | Delaware | 1647865 | 0 | 1752984 | 0 | 1752984 | 6.332 % | 20/12/2018 |
| Abigail P. Johnson | United States of America | 0 | 0 | 1752984 | 0 | 1752984 | 6.332 % | 20/12/2018 |
| EcoR1 Capital Fund Qualified, L.P. | Delaware | 0 | 1469186 | 0 | 1469186 | 1469186 | 5.3 % | 13/11/2018 |
| EcoR1 Capital, LLC | Delaware | 0 | 1747657 | 0 | 1747657 | 1747657 | 6.3 % | 13/11/2018 |
| Oleg Nodelman | United States | 0 | 1747657 | 0 | 1747657 | 1747657 | 6.3 % | 13/11/2018 |
| EcoR1 Capital Fund Qualified, L.P. | Delaware | 0 | 1469186 | 0 | 1469186 | 1469186 | 5.3 % | 13/11/2018 |
| Oleg Nodelman | United States | 0 | 1747657 | 0 | 1747657 | 1747657 | 6.3 % | 13/11/2018 |
| EcoR1 Capital, LLC | Delaware | 0 | 1747657 | 0 | 1747657 | 1747657 | 6.3 % | 13/11/2018 |
| FMR LLC | Delaware | 848996 | 0 | 3138986 | 0 | 3138986 | 11.374 % | 25/04/2018 |
| FMR LLC | Delaware | 848996 | 0 | 3138986 | 0 | 3138986 | 11.374 % | 25/04/2018 |
| Abigail P. Johnson | United States of America | 0 | 0 | 3138986 | 0 | 3138986 | 11.374 % | 25/04/2018 |
| Abigail P. Johnson | United States of America | 0 | 0 | 3138986 | 0 | 3138986 | 11.374 % | 25/04/2018 |
| Novartis Institutes for BioMedical Research, Inc. | 3948482 | 14.3 % | 23/04/2018 | |||||
| Novartis AG | 3948482 | 14.3 % | 23/04/2018 | |||||
| Novartis Institutes for BioMedical Research, Inc. | 3948482 | 14.3 % | 23/04/2018 | |||||
| Novartis AG | 3948482 | 14.3 % | 23/04/2018 |